Unvaccinated People 20 Times More Likely to Die From COVID: Texas Study

Brasil Notícia Notícia

Unvaccinated People 20 Times More Likely to Die From COVID: Texas Study
Brasil Últimas Notícias,Brasil Manchetes
  • 📰 WebMD
  • ⏱ Reading Time:
  • 41 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 20%
  • Publisher: 51%

During the month of September, Texans who weren’t vaccinated against COVID-19 were 20 times more likely to die from COVID-19 and related complications than those who were fully vaccinated, according to a new study.

The protective effect of vaccination was most noticeable among younger groups. During September, the risk of COVID-19 death was 23 times higher in unvaccinated people in their 30s and 55 times higher for unvaccinated people in their 40s.

In addition, there were fewer than 10 COVID-19 deaths in September among fully vaccinated people between ages 18-29, as compared with 339 deaths among unvaccinated people in the same age group. Then, looking at a longer time period -- from Jan. 15 to Oct. 1 -- the researchers found that unvaccinated people were 45 times more likely to contract COVID-19 than fully vaccinated people. The protective effect of vaccination against infection was strong across all adult age groups but greatest among ages 12-17.

“All authorized COVID-19 vaccines in the United States are highly effective at protecting people from getting sick or severely ill with COVID-19, including those infected with Delta and other known variants,” the study authors wrote. “Real world data from Texas clearly shows these benefits.”

Resumimos esta notícia para que você possa lê-la rapidamente. Se você se interessou pela notícia, pode ler o texto completo aqui. Consulte Mais informação:

WebMD /  🏆 709. in US

Brasil Últimas Notícias, Brasil Manchetes

Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.

UK to roll out COVID-19 antiviral drug trial this month -Health Security AgencyUK to roll out COVID-19 antiviral drug trial this month -Health Security AgencyBritain will start to roll out Merck's molnupiravir COVID-19 antiviral pill through a drug trial later this month, Susan Hopkins, Chief Medical Adviser at the UK Health Security Agency said on Sunday.
Consulte Mais informação »

Pfizer, BioNTech again seek U.S. nod for COVID-19 vaccine boosters in all adultsPfizer, BioNTech again seek U.S. nod for COVID-19 vaccine boosters in all adultsPfizer Inc and BioNTech once again requested the U.S. Food and Drug Administration (FDA) on Tuesday to authorize booster doses of their COVID-19 vaccine in all adults.
Consulte Mais informação »

U.S. administers 430.9 mln doses of COVID-19 vaccines - CDCU.S. administers 430.9 mln doses of COVID-19 vaccines - CDCThe United States has administered 430,927,624 doses of COVID-19 vaccines in the country as of Sunday morning and distributed 534,081,335 doses, the U.S. Centers for Disease Control and Prevention said.
Consulte Mais informação »

COVID-19 Cases Surge Across EuropeCOVID-19 Cases Surge Across EuropePublic health experts in the U.S. are closely watching activity in Europe, as it can often be a bellwether for what’s next in the pandemic
Consulte Mais informação »

Covid-19 Vaccines and Myocarditis Link Probed by ResearchersCovid-19 Vaccines and Myocarditis Link Probed by ResearchersResearchers investigating rare heart-related risks linked to Covid-19 vaccines are exploring several emerging theories, including one centered on the spike protein made in response to the shots
Consulte Mais informação »

Hospitals face staffing shortages, employee clashes as COVID-19 vaccine mandate loomsHospitals face staffing shortages, employee clashes as COVID-19 vaccine mandate loomsExperts across the country worry that forcing the nation's already-stressed hospitals to implement vaccine mandates may push needed workers to quit.
Consulte Mais informação »



Render Time: 2025-03-10 00:11:58